131 related articles for article (PubMed ID: 8841589)
1. Structure of translation initiation region of c-myc mRNA and thermostability of the c-myc mRNA/antisense ODN complex.
Tanaka T; Kurihara Y; Sakamoto T; Furusawa M; Kobayashi A; Katahira M; Takeuchi K; Sugimoto N; Uesugi S
Nucleic Acids Symp Ser; 1995; (34):135-6. PubMed ID: 8841589
[TBL] [Abstract][Full Text] [Related]
2. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
[TBL] [Abstract][Full Text] [Related]
3. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
[TBL] [Abstract][Full Text] [Related]
4. Walking along human c-myc mRNA with antisense oligodeoxynucleotides: maximum efficacy at the 5' cap region.
Bacon TA; Wickstrom E
Oncogene Res; 1991; 6(1):13-9. PubMed ID: 1997945
[TBL] [Abstract][Full Text] [Related]
5. Reduction of cisplatin cytotoxicity on human lung cancer cell lines with N-myc amplification by pretreatment with N-myc antisense oligodeoxynucleotides.
Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1995; 15(1):37-43. PubMed ID: 7733638
[TBL] [Abstract][Full Text] [Related]
6. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
7. Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation.
Dias N; Dheur S; Nielsen PE; Gryaznov S; Van Aerschot A; Herdewijn P; Hélène C; Saison-Behmoaras TE
J Mol Biol; 1999 Nov; 294(2):403-16. PubMed ID: 10610767
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of hybridization of mRNA of c-myc oncogene with 111In-labeled antisense oligodeoxynucleotide probes by high-pressure liquid chromatography.
Dewanjee MK; Ghafouripour AK; Kapadvanjwala M; Samy AT
Biotechniques; 1994 May; 16(5):844-6, 848, 850. PubMed ID: 8068339
[TBL] [Abstract][Full Text] [Related]
9. Influence of mRNA self-structure on hybridization: computational tools for antisense sequence selection.
Toschi N
Methods; 2000 Nov; 22(3):261-9. PubMed ID: 11071822
[TBL] [Abstract][Full Text] [Related]
10. c-myc antisense oligonucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells.
Collins JF; Herman P; Schuch C; Bagby GC
J Clin Invest; 1992 May; 89(5):1523-7. PubMed ID: 1569190
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of MAP kinase antisense oligonucleotide on angiotensin II-induced c-myc gene expression and proliferation of rat cardiac fibroblast.
Ding B; Huang SL; Zhang SQ; Li YX
Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):934-40. PubMed ID: 11270995
[TBL] [Abstract][Full Text] [Related]
12. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
[TBL] [Abstract][Full Text] [Related]
13. Prediction of VEGF mRNA antisense oligodeoxynucleotides by RNA structure software and their effects on HL60 and K562 cells.
Fei J; Zhang Y
Cell Biol Int; 2005 Sep; 29(9):737-41. PubMed ID: 15985377
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
Zhang SQ; Ding B; Guo ZG; Li YX
Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
[TBL] [Abstract][Full Text] [Related]
15. Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides.
Junghans M; Loitsch SM; Steiniger SC; Kreuter J; Zimmer A
Eur J Pharm Biopharm; 2005 Jul; 60(2):287-94. PubMed ID: 15939239
[TBL] [Abstract][Full Text] [Related]
16. A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation.
Capeáns C; Piñeiro A; Domínguez F; Loidi L; Buceta M; Carneiro C; Garcia-Caballero T; Sanchez-Salorio M
Exp Eye Res; 1998 May; 66(5):581-9. PubMed ID: 9628805
[TBL] [Abstract][Full Text] [Related]
17. C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes.
Hashiramoto A; Sano H; Maekawa T; Kawahito Y; Kimura S; Kusaka Y; Wilder RL; Kato H; Kondo M; Nakajima H
Arthritis Rheum; 1999 May; 42(5):954-62. PubMed ID: 10323451
[TBL] [Abstract][Full Text] [Related]
18. Two haplotypes of 5' untranslated region in L-myc gene with different internal ribosome entry site activity.
Kumimoto H; Yamane Y; Ishizaki K
Int J Oncol; 2005 Jan; 26(1):287-93. PubMed ID: 15586251
[TBL] [Abstract][Full Text] [Related]
19. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
Gutierrez AJ; Matteucci MD; Grant D; Matsumura S; Wagner RW; Froehler BC
Biochemistry; 1997 Jan; 36(4):743-8. PubMed ID: 9020771
[TBL] [Abstract][Full Text] [Related]
20. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
Ebinuma H; Saito H; Kosuga M; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Okuyama T; Ishii H
J Cell Physiol; 2001 Jul; 188(1):56-66. PubMed ID: 11382922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]